European Scale Fund Negotiates Investment in Voice AI Company ElevenLabs
Sources say that the newly established European technology growth fund Scaleup Europe Fund is negotiating an investment with UK-based AI company ElevenLabs. The fund has a size of €5 billion and is managed by Sweden's EQT. The amount, valuation, and whether it will lead or co-invest are yet to be determined, and both parties declined to comment on the reports.
The fund is anchored by €1 billion from the European Commission, with participation from Allianz, APG, Novo Holdings, and others. Since its establishment earlier this year, it has participated in rounds for unlisted European tech companies such as Iceye, Lovable, Mistral AI, and Tandem Health, covering sectors like AI, quantum, semiconductors, robotics, energy, aerospace, and biotechnology. Its goal is to fill the late-stage financing gap and reduce the trend of companies seeking funding in the U.S.
ElevenLabs is known for its generative voice and conversational AI. In February, it completed a $500 million Series D round led by Sequoia, with a valuation of about $11 billion, and participation from firms like a16z and ICONIQ. The company is headquartered in the UK, with founders from Warsaw and an expanding team in Poland. Reports indicate that the current round has intentions exceeding $500 million, but this does not guarantee a deal.
The UK is not in the EU, yet negotiations continue, indicating that managers view European talent and strategic sectors more broadly than just their registered locations. If late-stage checks materialize, it would mean public funds and private equity jointly extending the life of voice models rather than starting new training clusters.
In market mechanisms, this is a rumor about a sovereign growth fund's project, not a public pricing. The beneficiaries are those in late-stage rounds that can access European public anchor funds; underwriting and secondary markets have not yet opened. Funds remain at private equity valuations, with $11 billion being the anchor from the previous round, and the current figures are not written into contracts.
Source: Public information
ABAB AI Insight
The EU's allocation of €5 billion to EQT acknowledges that Europe lacks seeds but needs growth funds capable of writing billion-euro checks. ElevenLabs is already an $11 billion company on Sequoia's books; securing European fund investment is akin to rebranding U.S. venture capital assets with a European label. Registered in London and with a team in Poland, it straddles the ambiguous definition of a "European company."
The capital path involves public funds co-investing in already priced assets, reducing the likelihood of being entirely acquired by U.S. growth funds in the next round, without altering the dollar revenue structure of the products. The competition in voice generation is between labs in the U.S. and the UK, and the fund is buying minority stakes that remain on European balance sheets. The investment in Mistral indicates that the same fund is placing orders at both ends of large models and voice applications.
This is analogous to French public funds investing in Mistral and German industrial funds in robotics: strategic autonomy is first written as shareholding, then as supply chain. The industry is at a stage where European growth funds are recognizing companies that have already been priced by the U.S.
Structural judgment belongs to capital concentration. The mechanism is that late-stage gaps are anchored by Brussels and managed from Stockholm, with checks flowing to a few companies that can tell a global story; the way to reduce outflows is to keep the next round within European legal entities, not just to keep training within the European grid.
ABAB News · Cognitive Law
- When the growth gap is filled, what is often bought are companies that have already been priced by the U.S.
- Headquarters can be in London, but the strategic label can still be written as European.
- Public funds co-investing first changes the shareholder roster, then changes the training location.